Back

Modelling Kearns-Sayre syndrome cardiomyopathy in human iPSC derived cardiac organoids

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Topics in paediatric cardiology (3) Paediatric Cardiology ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Arka Provo Das

Frankfurt Am Main (Germany)

7 More presentations in this session

Presentation thumbnail
Congenital Zika syndrome: is the ECG-age by artificial intelligence a biological marker?
Doctor G. Paixao (Belo Horizonte, BR)
Abstract Slides Video
Presentation thumbnail
Family history of hypertension, diabetes, and high cholesterol with the risk of worsening structural and functional cardiac damage in youth: a 24-year longitudinal study
Doctor D. Corsi (New Brunswick, US)
Abstract Slides Video
Presentation thumbnail
Feasibility of implementing life essential 8 cardiovascular health metrics to assess cardiovascular health in malaysian children
Doctor H. Lim (Wilayah Persekutuan Kuala Lumpur, MY)
Abstract Slides Video
Presentation thumbnail
Experiences and current practices of cardiovascular health assessment for primordial prevention in children and adolescents: a qualitative study
Doctor H. Lim (Wilayah Persekutuan Kuala Lumpur, MY)
Abstract Slides Video
Presentation thumbnail
Maternal hyperthyroidism and cardiac structure and function in the newborn
Miss C. Vollmond (Herlev, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Topics in paediatric cardiology (3)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Novel mitochondria-targeted therapy AP39 limits mitochondrial dysregulation and diastolic dysfunction in 2D & 3D human models of diabetic cardiomyopathy
thumbnail
Congress Presentation
Advancing cardiac 3D organoid-on-chip: integrating iPSC-derived MELAS syndrome models to study electromechanical synchronicity and cardiac memory using contactless technology
thumbnail
Congress Presentation
HFWM: Integrating metabolomics and proteomics to identify novel drug targets for heart failure and atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources